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Autizmus je neurologická choroba ktorá postihuje prevažne chlapcov. Preukazuje sa anti-
sociálnym a stereotypným správaním s nízkou úrovňou empatie. Doposiaľ sa pracovalo 
hlavne s pôvodom genetickým, no posledné roky sa štúdie začali sústreďovať aj na imunitný 
systém matky. Táto práca zhŕňa hlavne poznatky o materských autoreaktívnych protilátkach 
ktoré rozpoznávajú špecifické proteíny dôležité pre vývoj mozgu. 
Sústreďuje sa na funkciu jednotlivých proteínov v neurogenezii a ich možné prepojenie s 
patologickým konektomom autistického mozgu.  
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Abstract 
Autism is a neurological disease that affects predominantly boys. It is characterised by anti-
social and stereotypical behaviour with a low level of empathy. Most of the studies have 
been focusing on the genetic aetiology of this disease, however in the past years research 
has focused on the role of maternal immune system. This thesis summarizes information 
predominantly about maternal autoimmune antibodies that recognize specific proteins 
important in neurogenesis.  
It is focusing on the function of these proteins in neurogenesis and their possible correlation 
with the pathological brain connectome in autism.  
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Autism spectrum disorder (ASD) represents a group of complex neuro-developmental 
conditions characterised by a set of typical features. These include deficits in social-emotional 
reciprocity, such as verbal or non-verbal communication or developing and understanding 
relationships, accompanied with repetitive and restrictive behaviour (American Psychiatric 
Association,2013).  Various aetiologies have been associated with this disorder, ranging from 
genetic to immune disturbances, suggesting that it has also various subtypes. The effect of 
maternal immune system has been long discussed with relation to autism, in recent years 
maternal anti-brain antibodies and their corresponding antigens have been detected 
(Braunschweig et al., 2008). When it comes to the connectome in ASD, , it has been shown 
that large-scale (whole-brain) connectivity in ASD is altered. While some studies have found 
over-connected neural systems (Belmonte et al., 2003) other studies demonstrated deficit in 
connections between multiple areas in the brain (Just et al., 2004) .  
The central goal of this work is to examine plausible relationships between the 
presence of maternal antibodies against foetal brain proteins during brain development and 
future alternation of the whole-brain connectome in ASD.  
In the following chapters, specific proteins that have been so far associated with 
reactive maternal antibodies will be described and their possible contribution to the 












Autism spectrum disorder  
 
World Health Organisation groups ASD in the ICD-10 under the name “Pervasive 
developmental disorders“ along with Rett or Asperger syndrome. Autism can also be classified 
as “childhood” or “atypical”. The difference between them is the onset time of symptoms and 
the amount of them presented (World Health Institution, 2016). 
First described in 1943, the diagnosis of autism and research of its aetiologies have 
come a long way. First study was purely observational, where the behaviour of 11 children 
was described not only thanks to direct observation but also because of detailed journals kept 
by the parents of these children (Kanner, 1943). 
The aetiologies of autism have been discussed for a very long time. It is still unclear as 
to what the underlying causes are. There have been theories expressed both for genetic 
(Bailey et al., 1995; Klei et al., 2012; Lichtenstein et al, 2010; Rosenberg et al., 2009) and 
environmental roots. Under “environmental” there can be understood several causes such as: 
stress during pregnancy (Beversdorf et al., 2005; Ronald et al., 2011), advancing parental age 
(Croen et al. , 2002; Lauritsen et al., 2005), or  gestational diabetes mellitus (P. Krakowiak et 
al., 2012; Nahum Sacks et al., 2016). It is likely that ASD rises after an interaction of both 
genetic and environmental factors during neurogenesis.  
Brain connectivity in autism  
 
 The human brain must work with huge amounts of information constantly. 
Therefore, it has developed a system, in which its different areas collaborate effectively to 
give rise to our perception and interaction with the world. The word “connectivity” however, 
is very broad. There can be several types recognized, such as: local connectivity based on 
neural communication or long-range connectivity between different parts of the brain. There 
is also a significant difference between physical connectivity (synapses) and computational 
connectivity – the information transfer. 
We can also come across functional vs. effective connectivity, where functional is basically 
statistical dependence among neurophysiological events and effective connectivity is what is 
trying to explain it.  
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The notion of looking at brain connectivity in patients with autism isn´t something novel. 
Since the development of various brain-imaging techniques (especially functional magnetic 
resonance imaging and diffuse tensor imaging), the number of studies has abruptly 
increased. The results have been inconsistent, but largely agree that patients with autism 
have a high local connectivity and low long-range one (reviewed in Belmonte, 2004). It is 
believed that the decreased long-range connectivity limits effective information integration 
between multiple brain areas of both hemispheres which is essential for higher cognitive 
functions. What are the exact mechanisms responsible for abnormal axonal connectivity 
remains an enigma.  We can speculate that abnormal connectivity may be a consequence of 
a pathological process that interfere with axonal growth, sprouting and pruning during brain 
development. The presence of maternal anti-bodies against the fetal brain during pregnancy 
can represents one of the pathological processes. 
 
Maternal immune system  
 
Role of maternal immune system in pregnancy 
 
Maternal immune system is in a delicate balance all throughout the pregnancy. There 
are three stages to be considered. First, highly inflammatory stage during which woman can 
experience fever and nausea, because the blastocyst is being integrated into the uterus lining. 
Second is the developmental stage that is also regarded to as anti-inflammatory, since the 
foetus is developing and there must be a balance, in order that it’s not rejected by the 
mother’s body but also protected from various pathogens. Last stage, the delivery, is achieved 
again by renewed inflammation (reviewed in Mor et al., 2010).  
It is during the “anti-inflammatory” stage that problems can occur, as this is the stage 
when the foetus goes through development including the brain. One of the constituents of 
immune system that aid to passive foetal protection against pathogens are maternal 
immunoglobulins of the G subclass (IgG antibodies). They get transferred through placenta 
starting at around week 18 and can persist in the child up to even 3 months post-natal (Garty 
et al., 1994; Heininger et al., 2006).  While most of these IgG antibodies are immunoprotective, 
also auto-reactive IgG antibodies can transfer along with them through placenta.  
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 Blood-brain barrier  
 
 The blood-brain barrier (BBB) is a special interface between the cerebrospinal fluid in 
circulation and the brain. This term encompasses mainly special properties of central nervous 
system (CNS) vessels, along with tight-junctions and specific transporters to make sure the 
brain environment has stable conditions. Another barrier used by the CNS is the blood- 
cerebrospinal fluid barrier (BCSFB), which separates blood from the CSF though epithelial cells 
of the choroid plexus. Even though the barriers should be unbreachable to antibodies, there 
is a growing evidence that during early stages of development they are not yet fully formed 
and therefore proteins and antibodies can still pass through. Various environmental factors 
may increase the permeability of BBB as well (reviewed in Saunders et al., 2012). 
One of the earliest detections of IgG antibodies in the cerebrospinal fluid was done by 
Adinolfi et al., in 1976. Along with IgG also higher levels of alpha fetoprotein and albumin have 
been observed (Adinolfi et al. , 1976).  
 
Maternal immune system dysregulation and autism  
 
The association of “abnormal” maternal immune system and consequent diagnosis of 
autism in their offspring has been shown before. It has been even reported that only an 
activated immune response to a pathogen during pregnancy can lead to developmental 
changes in the foetus. This been shown by studies examining a correlation between a hospital 
admission during pregnancy and ASD, showing a higher risk of ASD cases among children of 
mothers that have been hospitalized due to an infection during pregnancy. (Lee et al., 2015; 
Zerbo et al., 2015) 
The association has been shown for example with human influenza virus in pregnant 
mice, which resulted in highly abnormal behavioural trends in their offspring, such as lower 
interest in exploration of novel places and objects, or deficits in social interactions (Shi et al. , 
2003).  Another examples of diseases associated with autism include measles-rubella-mumps 
(MMR) antibodies (Singh et al, 2002), polyoma virus (Lintas et al., 2010) or Borna disease virus 
(Lancaster et al., 2007). This however doesn´t indicate that the pathogens as such are 
responsible for the correlation, rather the immune system response caused by them.  
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 Immune response to virus infection and inflammation consists of an increase in the 
level of cytokines and chemokines. These are signal molecules in a cascade that runs after 
immune activation  (Borish et al., 2003). Various studies have found some of them being 
expressed in a developing and adult brain, suggesting their roles in neurodevelopment, 
ranging from neuronal and glial migration, cell survival to proliferation of neural precursors 
(reviewed in Stolp, 2013).  
Their disrupted levels have been linked to autism in the past. Jones et al. have found 
significantly higher levels of these molecules in mid-gestational samples of mothers of children 
with ASD with intellectual disability (Jones et al., 2017), higher levels of chemokines in 
amniotic fluids from mothers from a Historic Birth Cohort in Denmark have also been reported 
(Abdallah et al., 2012). Increased levels of various chemokines and cytokines in dried neonatal 
plasma samples of children later diagnosed with ASD have also been reported. (Ashwood et 
al., 2011a, 2011b; Krakowiak et al., 2017) These findings suggest that a maternal immune 
response during pregnancy, may cause a disbalance in the developing brain and result in an 




 The correlation of autoimmune diseases in families and their offspring having autism 
was started by a case study, presenting a child with ASD from a family with a history of 
autoimmune diseases. (Money et al., 1971) In a study which consisted of 61 ASD patients 
and 46 controls, it was reported that the mean number of autoimmune diseases was higher 
in families with autistic offspring, 46% of the ASD patients had two or more members of the 
family with autoimmune disorders. The risk of autism was increased from 1.9 to 5.5 as the 
number of family members with autoimmune disorder has increased from 1 to 3 
respectively. (Comi et al., 1999)  
 Increased chance of ASD in families with autoimmune disease has been confirmed by 
later studies and meta-analysis. Specific autoimmune diseases that have shown a correlation 
with autism include: eczema/psoriasis, rheumatoid arthritis, hypothyroidism, type 1 diabetes 
and systemic lupus erythematosus (Atladóttir et al., 2009; S.-W. Chen et al., 2016; Vinet et 
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al., 2015; Wu et al., 2015). Maternal asthma has also been implicated with ASD in the 
offspring (Croen et al., 2018). Most studies have however shown none or very weak 
association with paternal autoimmune disease in contrast to maternal (Keil et al., 2010). This 
may suggest that the most important link between these diseases and the resulting ASD 
diagnosis is the pre-natal environment in which neurogenesis occurs, therefore the state of 




Earlier findings  
 
One of the first studies to connect maternal antibodies with autism was done by Warren 
et al. in 1990. In a sample of 11 children with ASD, their siblings and 20 controls they have 
found significantly higher reactivity of peripheral maternal blood against lymphocytes of the 
autistic children.  Throughout the years, various studies have found reactive antibodies in the 
plasma of mothers of autistic children. Some were anti-MBP (myelin basic protein) (Singh et 
al., 1993), other targeting brain endothelial cells and nuclei (Connolly et al., 1999) while others 
associated reactive antibodies with regions such as caudate nucleus, cerebral cortex or 
cerebellum (Singh et al., 2004).  
Dalton et al. have shown that a serum of a mother of three children (1 normal, 1 with 
autism and 1 with severe specific language disorder) had antibodies reactive to rodent 
Purkinje cells and other neurons. After injecting mice with this serum, they have exhibited 
differences in exploration and motor coordination compared to mice injected with control 
serum (Dalton et al., 2003). 
 Studies expanding on these findings have uncovered reactivity to specific protein bands. 
In a study of 29 subjects using archived mid-gestational blood specimens on rodent neuronal 
tissue, bands at 100-kDa in various areas of autistic subjects have been found. Denser bands 
were also observed at 73-kDa for both autistic children and their non-autistic siblings than in 
controls (Singer et al., 2006). Part of these findings has been confirmed in a study with a larger 
sample – 84 autistic children and two control groups - 49 children with mental retardation or 
developmental delay (MR) and 160 randomly selected children (GP). By Western-blot, 
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reactivity to band at 39-kDa was predominantly found in children with autism (7%, compared 
to 0% in MR children and 2% in GP) with simultaneous reactivity to bands at 39kDa and 73kDa  
(Croen et al., 2008). 
Reactivity to 73kDa has also been observed alongside with 37-kDa bands (Braunschweig 
et al., 2008). Individual reactions to each band have been observed significantly higher in 
mothers of children with autism (AU). Reactivity to both bands at the same time was observed 
only in the AU group. These bands – 37, 39 and 73-kDa have either alone or in combination 
been associated with problems of development in verbal and non-verbal language, 
sleep/wake cycle disturbances and a delay in neurodevelopment (Piras et al., 2014). They have 
also correlated 45 and 62-kDa antibodies to autism severity. 45-kDa has been associated with 
cognitive impairment, while 62-kDa with motor stereotypes. Both correlate with larger head 
circumference. These findings correlate with findings by Goines et al., in which the 45-kDa 
antibodies were more associated with the diagnosis of autism, while 62-kDa with broader 
autism spectrum disorder diagnosis. (Goines et al., 2011) Reactivity to the 37 and 73-kDa 
antigens have been associated with impaired use of expressive language, as well as an 
association with higher scores on the Irritability subscale of the ABC was made. (Braunschweig 
et al., 2012)  
Identified Bands Association Study 
37-kDa -impaired use of expressive 
language  
-higher scores on the irritability 
subscale of the ABC 
Braunshweig et al. 2008 
39-kDa -problems with development of 
verbal and non-verbal language 
-delay in neurodevelopment 
Croen et al. 2008 
Piras et al. 2014 
45-kDa -cognitive impairment  
-larger head circumference 
Piras et al. 2014 
Goines et al. 2011 
62-kDa -motor stereotypes Piras et al. 2014 
Goines et al. 2011 
73-kDa -problems with development of 
verbal and non-verbal language 
-delay in neurodevelopment 
-higher scores on the irritability 
subscale of the ABC 
Braunshweig et al. 2008 
Singer et al. 2006 
Croen et al. 2008 
Table 1 - summary of identified protein bands against which the antibodies were reactive and associations to specific 




Animal model studies   
 
 Several studies have looked at the effect of maternal antibodies using animal models. 
As mentioned before, in one study, mice injected with a serum from a mother of 3 children, 
of which one was diagnosed with ASD, exhibited differences in exploration and motor 
coordination compared to mice injected with control serum (Dalton et al., 2003). Kim and his 
colleagues (2016) have used a special strain of mice - BTBR T+tf/J (BTBR) which is a good 
animal model for autism because of their lower social interactions, unusual vocalisation and 
highly repetitive behaviour. They have been shown to have much higher levels of IgG in 
serum, brain deposits as well as anti-brain IgG antibodies than other, highly social strain 
C57BL/6. BTBR mice had higher levels of brain reactive IgG than FVB (highly social control 
strain) for whole brain, striatum and substantia nigra. Deposited IgG levels in the 
hippocampus, cerebellum or cortex were also significantly higher in the BTBR mice (Kim et 
al., 2016) It has also been proven thanks to animal models that even a single low dose of 
purified brain-reactive IgG antibodies from mothers of children with ASD produced offspring 
with anxiety-like behaviour and significant impairments in sensory and motor development 
(Braunschweig et al., 2012).  
Offspring of mice that have been injected with purified IgG antibodies during days 13-
18 of gestation from mothers of children with ASD have exhibited increased activity 
compared to control group as adolescents. As adults, they have displayed a deficit in social 
interactions and a behaviour similar to anxiety. (Singer et al., 2009) Autistic-like stereotypical 
behaviour in mice has also been observed, after their mothers have been injected with IgG 
antibodies on day 14. Alternations to social behaviour have also emerged compared to the 
control group of mice (Camacho et al., 2014).  
Another animal model beside mice and rats that has been used for studying maternal 
antibodies in relation to autism is rhesus monkey. This model is easier to study as primates 
are closer in behaviour to humans than mice. One study has used purified IgG antibodies 
from mothers of children with ASD, injecting 4 pregnant rhesus monkeys and another 4 were 
injected with IgG from mothers of normally developing children. All were injected with the 
serum on three days during gestation (days 27,41, and 55). The offspring of monkeys 
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injected with IgG from mothers of children with ASD have exhibited stereotypical and 
hyperactive behaviour compared to controls (Martin et al., 2008). Another study using 
rhesus monkeys was carried out by injecting six doses of purified IgG antibodies during first 
and second trimesters of their pregnancy. The offspring has been observed for duration of 2 
subsequent years. What the researchers have found was that mothers of monkeys that have 
been administered IgG antibodies from mothers of children with ASD have become more 
protective of their offspring than control groups in the early development. The IgG-ASD 
primates have exhibited differences in social behaviour and males have had an enlarged 
brain volume with biggest difference being in the white matter in the frontal lobes. (M. D. 
Bauman et al., 2013)  
  
Figure 1 – Scheme showing the impact of maternal antibodies on precursol cell function. (A) – Mouse, Pax6+ RG cells begin 
moving from the VZ later in neurogenesis (B) – In rhesus monkey they translocate very soon after the start of neurogenesis 
(C) – the neocortex of prenatal mouse that has been exposed to maternal antibodies, where the RG cells move into the SVZ 
much sooner than they should (Taken from Martínez-Cerdeño et al., 2016)  
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A study has been done that has focused solely on specific antigens of maternal 
antibodies. What they have found was that these antibodies bind to radial glial cells during 
development. Radial glial cells are primary cortical precursor cells during cortical 
development that generate neurons and astrocytes. During neurogenesis, redial glial cells 
generate cortical neurons. They are in the ventricular lumen and throughout the 
developmental stage move into the subventricular zone of the embryonic neocortex. (Figure 
1) When maternal antibodies associate with the radial glial cells, they are released into the 
SVZ much earlier. This may influence the neuronal migration, which could mean that new 
cells would arrive prematurely into cortical gray matter and disrupt developing networks. In 
dorsal neocortex abnormal patterns of proliferation were observed, where the excitatory 
projection neurons are produced. Same was reported in ganglionic eminence, production 
site of interneurons. (Martínez-Cerdeño et al., 2016) This abnormal neurogenesis may 
potentially lead to the altered connectome present in patients with ASD.  
 
Identified Proteins  
  
 





Thanks to spectrometry peptide sequencing, the proteins corresponding to the identified 
bands 37-,39-, and 73-kDa were identified as: cypin, stress-induced phosphoprotein 1 (STIP1), 
collapsin response mediator proteins 1 & 2 (CRMP1 & 2), lactate dehydrogenase A & B (LHD), 
and Y-box-binding protein (YBX-1) (Braunschweig et al., 2013). Reactivity to a combination of 
specific antigens was shown in 23% mothers of children with ASD as opposed to 1% in control 
group.  
Mice injected with a series of peptide epitope sequences of LDH, STIP1 and CRMP1 have 
demonstrated stereotypical self-grooming behaviour, avoiding social interactions with failure 
at reciprocating juvenile play with peers. (M. Bauman et al., 2018) Another study focusing 
solely on plasma samples that contained antibodies specific for 37-kDa (LDH) and 73-kDa 
(STIP1 and CRMP1) has demonstrated an enlargement of brain in size and weight along with 
higher cortical neuron volume in mice exposed to the sample with reactive antibodies 




 Cypin, also known as guanine deaminase, is 
involved in purine catabolism, where it catalyses  
hydrolytic deamination of guanine into xanthine 
(Hitchings et al., 1944). Apart from metabolic reactions it 
has been shown that cypin is an important protein in 
neurogenesis. It promotes microtubule assembly and 
regulates dendrite patterning in hippocampal neurons 
(Akum et al., 2004). This has been shown by knock-out 
model in which cypin mRNA was prevented from 
maturation using mutated U1 small nuclear RNA 
(snRNA). The neurons that had this mutant snRNA 
indicated small or non-existent levels of cypin and fewer 
dendrites than normal.  
Figure 3- Expression of cypin in developing hippocampal 
neurons. Cypin is expressed as early as 4 days and continues 
to be until the neurons mature. It is also expressed in 
dendrites (MAP2) and axons (white arrows in Merge). 
(Taken from: Akum et al. 2004)  
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Another animal study has shown that single substitution mutations that have disrupted the 
enzymatic activity in rats, have rendered cypin unable to promote dendrite branching in 
hippocampal neurons. (Fernández et al., 2007)  
 Cypin is also known to interact with a postsynaptic density 95 (PSD-95/SAP-90) 
protein. PSD-95 is a membrane associated guanylate kinase, playing an important role in the 
structural organisation of glutamate receptors and their associated signalling networks at 
the excitatory synapses. Cypin is also located in axons and several nerve terminals and 
increases dendrite branching by negatively regulating PSD-95 and promoting microtubule 
polymerization (Firestein et al., 1999) Another protein interacting with cypin is snapin, 
binding to CRMP homology domain of cypin, which has been identified to be the domain 
responsible for promoting microtubule assembly (Akum et al., 2004) and competes with 
tubulin heterodimer that binds to cypin (Chen et al., 2005). If cypin expression is inhibited, 




The expression pattern of CRMP1 is like that of CRMP2 in the embryonic and postnatal 
cerebral cortex (Wang & Strittmatter 1996). Recent findings suggest that they both mediate 
Sema3A signalling, which regulates dendritic spine maturation, however through distinct 
signalling pathways (Makihara et al., 2016). Both have been shown to be involved in axonal 
guidance and synergic control of dendritic projection. (Yamashita et al., 2012)  
A study done on CRMP2 gene-deficient (crmp2-/) mice has shown that these mice had 
irregular development of dendritic spines in cortical neurons and density of dendritic spines 
in the cortical layer V pyramidal neurons was reduced. This protein is also responsible for the 
formation and maturation of dendritic spines along with the process of dendritic spine 
plasticity. (Zhang et al., 2018)  
 CRMP2 has also been shown to have a synergistic relationship with CRMP4 in regulating 
dendritic development and having an important role in proper bifurcation of apical dendrite 
of CA1 pyramidal neurons. (Niisato et al., 2013) By suppressing CRMP2 expression an 
accumulation of multipolar cells and suppressed neurite outgrowth can be seen. (Sun et al., 
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2010) This suggests that CRMP2 is needed for transition from multipolar to bipolar in 
directional neuronal migration as well as neurite outgrowth.  
Knock-out CRMP1 mice had shown hyperactivity along with impaired emotional and 
behavioural responses. (Yamashita et al., 2013) This protein has also been associated with 
regulating of neuronal migration in the cerebral cortex through Reelin signalling (Yamashita 
et al., 2006).  
 
Figure 4 – This image shows the morphology of CA1 pyramidal neurons. It is evident that proper phosphorylation of CRMP2 
is vital for proper bifurcation of these neurons and that together with CRMP4 they regulate dendritic development. (Taken 




 STIP1 or also known as stress-inducible phosphoprotein is a co-chaperone of heat 
shock proteins hsp70 and hsp90 in intracellular environment (Chen et al., 1996; Picard, 
2002). Extracellular STIP1 works as a ligand to prion protein and together they have an effect 
on neuroprotection and produce signals that rescue cells from apoptosis (Chiarini et al., 
2002; Zanata et al., 2002). Together they also have an effect on both neuritogenesis and 
survival of hippocampal neurons (Lopes et al., 2005), astrocyte development (Arantes et al., 
2009) and memory formation (Coitinho et al., 2007).  
 An animal study has shown that an increase in STIP1 shows no major phenotype but 
mice that had reduced STIP1 levels presented attentional deficits and hyperactivity (Beraldo 
et al., 2015). In other tasks however they have shown normal performance.  
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A study done by Ariza and his colleagues has demonstrated that administrating 
antibodies of mothers of children with ASD resulted in decrease of the number of spines in 
infragranular layers of frontal and occipital cortex (Ariza et al., 2017). The findings of these 
studies correlate with functions of STIP1 that have been previously identified. This study was 
however limited to the fact that the antibody administration was done only once, resulting 
in changes in layer V in frontal cortex and layer VI in the occipital lobe. Since human foetus 




Figure 5- Reconstruction of representative pyramidal neurons in infragranular layers of the cortex of mice treated with 
normal IgG antibodies and with maternal autoimmune antibodies. A-F: Frontal cortex, G-L: Occipital cortex. Apical dendrites 
are in yellow, axonal initial segments in green and basal dendrites in other colors. Asterics show basal dendrites with 









 The enzyme lactate dehydrogenase can be found in the foetal brains of rodents, in 
mitochondria, where it functions in cellular metabolism (Hashimoto et al., 2008). 
Mitochondrial dysfunction has been linked to ASD by several studies (Frye et al., 2011; Goh 
et al., 2014; Weissman et al., 2008). A significant increase in LDH and pyruvate has been 
reported in children with ASD compared to a control group in the study (Khemakhem et al., 
2017). This fits into reported abnormal energy metabolism in Saudi ASD patients, which have 
shown increased plasmatic levels of lactate and lactate oxidase (El-Ansary et al., 2010). This 
has also been shown in an animal study, where lower pH associated with higher lactate 
levels has been reported (Hagihara et al., 2018).  
 Even though LDH doesn´t have a part in neurogenesis, it is an important factor of 
cellular metabolism and therefore can contribute to pathological connectome in ASD by 
contributing to mitochondrial dysfunction. 
 
Networks (connectome)  
 
Connectivity is a major organizing principle of the nervous system and 
conceptualizing the brain as a network (the ‘connectome’) represents fundamental and 
innovative framework for understanding clinical brain disorders (Bullmore et al., 2009). 
Healthy brain is characterized by high efficiency of information transfer between brain 
regions at low connection cost in such a way that it optimizes balance between local 
functional segregation and global integration. This type of connectivity yields high 
complexity dynamics and maintains high processing power. Within human connectome, 
specific regions are characterized by very high connectivity and large information flow with 
other areas and therefore they are defined as network hubs.  
In human whole-brain network, hub regions play central role in the global integration 
of information processing and they are located mainly within parietal and (pre-)frontal lobes. 
Due to their central role within the human brain network and functional significance, they, 
however, represent brain’s Achilles heel. Hub damage will have a disproportionate impact 
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on the network’s global efficiency of information processing; and thus be more likely to 
result to clinical symptoms such as impairment of cognitive functions, that depend on 
integrative network processes (Honey et al., 2008) Hub damage was demonstrated in 
integrative disorders such as Alzheimer’s disease and schizophrenia and recently it has been 
postulated that damage of hubs may represent common mechanism crucial for development 
of any type of brain disorder (Crossley et al., 2014).  
 Connectivity in ASD has been discussed for a long time. Some people have argued 
that there is a surfeit of connectivity (Rubenstein et al., 2003), while other studies have 
shown examples of underconnectivity (Jakab et al., 2013). It seems as though both sides of 
the argument are right, high-local connectivity with a lot of cross-talk has emerged from 
abnormal neuronal and synaptic development and thereby causing hyper-arousal and 
potentially causing a weak central coherence – decreased long-range connectivity (Belmonte 
et al., 2003).  
 
 
Figure 6 - Network on the left is of a healthy brain, a combination of strong-local connectivity  along with selective long-
range one. Inputs (two arrows) are easily differentiated from noise (single arrow) and can be easily linked across regions. 
The network on the left is of an ASD patient, local-connections are too strong and not efficiently developed and therefore a 





Decreased functional connectivity has also been reported between praecuneus and 
medial prefrontal cortex and anterior cingulate cortex. These are part of default mode 
network, which is active during resting state. Correlation of the magnitude of connectivity 
and the severity of social and communication deficits has been observed as well (Assaf et al., 
2010). Hong et al. have also observed atypical connectome hierarchy, suggesting the inability 
of the brain in ASD patients to switching from hubs into long-range network communication. 
Diminished segregation of areas responsible for facial recognition and language as well as 
self-referential process has been reported. (Hong et al., 2019)  
All these processes tend to be highly impaired in ASD patients, suggesting that faulty 
differentiation of neurons and their reduced branching may be one of the reasons behind 
this.  
Hippocampus and amygdala 
 
 Abnormal structure of the hippocampus and amygdala have been implicated with 
ASD for a long time, as abnormal pattern of hippocampal development (Schumann, 2004) 
and its enlargement along with amygdala in young children and adolescents (Groen et al., 
2010; Schumann et al., 2009). However, some studies report an enlargement of 
hippocampus but not of amygdala. (Maier et al., 2015) Reduced complexity of dendritic 
branching of CA1 and CA4 neurons was found in the hippocampus of autistic brains, CA4 
neurons were smaller in children with ASD (Raymond et al., 1995).  
The role of CA2 neurons has also been shown in a study done by Hitti et al. by 
developing a genetically engineered mouse which has been shown to have these neurons 
altered. This alternation has caused loss of social memory, indicating that these neurons 
have a role in sociocoginitive memory processing which has also one of the areas ASD 
patients differ to controls. (Hitti et al., 2014) Alternation of the shape of hippocampus in 
young children has been observed, consistent with inward deformation of subiculum. (Dager 
et al., 2007) 
In memory retrieval, reduced whole brain connectivity between important hubs as 
hippocampus and fronto-parietal control region has been observed. This correlates with the 
reduced success of memory retrieval in ASD patients (Cooper et al., 2017).   
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Dendrite and spine modifications  
 
 Proper dendrite morphology is crucial for normal function of the nervous system. 
They are the most important elements of neurons that receive information. (Vetter, Roth, & 
Häusser, 2001) They form during development with at first slow dendrite growth, rapid 
period of dendritic extension and then a period of stabilization of dendritic arbour (Williams 
et al., 2004). Various dendrite number abnormalities have been reported in patients with 
ASD (Hutsler et al., 2010; Mukaetova-Ladinska et al., 2004), which correlates with the fact 
that cypin and CRMP have functions that modify it and therefore they can be associated with 
this pathological observation.   
 Reduced dendritic complexity has been observed in mutant mice strain C58/J, which 
has autistic-like behaviour. The number, size of dendritic processes and lengths of dendrites 
is lower in C58/J than in WT mice. These differences were reported in the prefrontal cortex 











Figure 7 – On the right is ramification pattern of pyramidal neurons in PFC, on the right in the hippocampus. C58/J is a 
mutant strain of mice with autistic-like behaviour. What can be observed is that the dendrites in this strain are shorter in the 

















Protein Function Possible pathology 
Cypin -Dendrite patterning (Akum et al, 2004) 
-Ligand of PSD-95 at excitatory synapses 
(Firestein 1999) 
-abnormalities in dendrite number  
(Hutsler et al., 2010; Mukaetova-
Ladinska et al., 2004) 
CRMP 
1/2 
-Dendritic spine maturation (Makihara et al. 
2016) 
-proper bifurcation of apical dendrite of 
CA1 pyramidal neurons (Niisato et al., 
2013) 
-Regulation of neuronal migration 
(Yamashita et al.,2006) 
-abnormalities in dendrite number  
(Hutsler et al., 2010; Mukaetova-
Ladinska et al., 2004) 
-Reduced complexity of dendritic 
branching of CA1 in the 
hippocampus (Raymond et al., 
1995) 
-Premature migration of RG cells 
from VZ to VZP  (Martínez-Cerdeño 
et al., 2016) 
STIP1 -survival of hippocampal neurons (Lopes et 
al.,2003) 
-abnormal pattern of hippocampal 
development (Schumann, 2004) 
LDH -cellular metabolism (Hashimoto et al., 
2008) 
-mitochondrial dysfunction in ASD 
(Frye et al., 2011; Goh et al., 2014; 
Weissman et al., 2008) 
Figure 8 – These graph show the total length of dendritic arbor in both PFC and HC. The lengths in the 




   
The goal main of this thesis was review current literature about the role of maternal 
autoantibodies in the pathogenesis of ASD. The literature demonstrates close relationship 
between the presence of inflammation and auto-antibodies against the foetal brain during 
the pregnancy and ASD. The evidence suggest that pathological antibodies often target 
proteins that physiologically play a crucial role in brain development. It involves proteins 
that are involved in the regulation of proliferation of neuronal precursors, neuronal 
migration, growth of axons and dendrites. The perturbation of these process can lead to the 
structural and morphological abnormalities not only at the cellular level, but it can affect 
neuronal circuit organization at the microscopic, mesoscopic or even at the whole brain 
level.  Modern imaging techniques especially diffuse tensor imaging have demonstrated 
substantial alteration of the connectivity in children with ASD which affects both local 
(regional) circuitry and the whole-brain connectome. It seems plausible that interference 
with axonal growth during brain development and widespread presence of auto-antibodies 
can substantially impact not only local axonal growth but also long-range axonal 
connections.  The magnetic resonance imaging techniques are being continuously developed 
and they provide better spatial resolution. Therefore, future experimental work in ASD 
models which will combine approaches to connectivity at multiple spatial scales can address 
these yet unresolved questions about the causal role of early exposure to maternal 
antibodies in the alteration of the whole brain connectome in ASD.   
Specific peptides to which maternal antibodies bind have been now identified for 
LDH, Cypin, CRMP1/2. (Edmiston et al., 2018) This brings a possibility to recognize these 
antibodies circulating maternal plasma even before pregnancy – to assess the risks. Given 
the heterogeneity of ASD subtypes, I believe it´s important to be able to be as specific as 
possible when it comes to its aetiologies. It has been shown that different possible causes 
have been associated with various behavioural changes, so I believe working on non-human 
primate animal models with specific proteins would be the best move forward, to assess 
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